A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer

Journal Article published Jul 2019 in Annals of Oncology volume 30 issue 7 on pages 1127 to 1133

Research funded by Astellas Pharma (10.13039/501100004948) | Novartis (10.13039/100004336) | Genentech (10.13039/100004328) | Merck (10.13039/100004334) | Inc. | Astellas (10.13039/100004324) | Bristol-Myers Squibb (10.13039/100002491) | Eli Lilly | AstraZeneca (10.13039/100004325) | Gritstone Oncology | Astellas (10.13039/100004324) | Xcovery

Authors: R.J. Kelly, F.A. Shepherd, A. Krivoshik, F. Jie, L. Horn

Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment

Journal Article published Jan 2016 in The American Journal of Geriatric Psychiatry volume 24 issue 1 on pages 70 to 80

Research funded by National Institute of Mental Health | Meso Scale Diagnostics | Pfizer | Merck | Roche | Baxter International | Synarc | Canadian Institutes of Health Research | Alzheimer's Association (NIRG-14-317353) | Takeda Pharmaceutical Company | Medpace | F. Hoffmann-La Roche | National Center for Advancing Translational Sciences | Genentech | National Institutes of Health (R25 MH071544/MH/NIMH) | U.S. Department of Defense | BioClinica | Alzheimer's Drug Discovery Foundation | Servier | Fujirebio Europe | Eisai | Sam and Rose Stein Institute for Research on Aging | GE Healthcare | Eisai | Bristol-Myers Squibb | Alzheimer's Disease Neuroimaging Initiative (W81XWH-12-2-0012U01 AG024904) | AstraZeneca | Novartis Pharmaceuticals Corporation | University of California | National Institute of Biomedical Imaging and Bioengineering | University of Rochester (KL2 TR000095) | Elan | National Institute on Aging | Biogen Idec | Biogen | Eli Lilly and Company | Araclon Biotech | Elan Pharmaceuticals, Inc. | EuroImmun | IXICO Ltd. | Janssen Alzheimer Immunotherapy Research & Development, LLC. | Johnson & Johnson Pharmaceutical Research & Development LLC. | NeuroRx Research | Neurotrack Technologies | Piramal Imaging | Avanir | EnVivo | Janssen Alzheimer Initiative | Medivation | Toyama | Transition Therapeutics

Authors: Nicholas D. David, Feng Lin, Anton P. Porsteinsson

The Role of Neutrophils in Asthma

Journal Article published Nov 2018 in Immunology and Allergy Clinics of North America volume 38 issue 4 on pages 629 to 638

Research funded by Teva Pharmaceutical Industries | Boston Scientific Corporation | Sanofi | Boehringer Ingelheim | Gilead Sciences | MedImmune | AstraZeneca | Genentech

Authors: Reynold A. Panettieri

Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study

Journal Article published Feb 2019 in Journal of the American Academy of Child & Adolescent Psychiatry volume 58 issue 2 on pages 287 to 296.e4

Research funded by Patient-Centered Outcomes Research Institute | National Institute of Mental Health | National Institute of Diabetes and Digestive and Kidney Diseases | Pfizer | Roche | Genentech | National Institutes of Health | Sunovion | Janssen Research and Development | Johnson and Johnson | Pharmaceuticals Bayer | Eunice Kennedy Shriver National Institute of Child Health and Human Development | American Academy of Child and Adolescent Psychiatry | NICHD | Shire | NICHD | Shire

Authors: Robert L. Findling, Nora K. McNamara, Mani Pavuluri, Jean A. Frazier, Moira Rynn, Russell Scheffer, Vivian Kafantaris, Adelaide Robb, Melissa DelBello, Robert A. Kowatch, Brieana M. Rowles, Jacqui Lingler, Jian Zhao, Traci Clemons, Karen Martz, Ravinder Anand, Perdita Taylor-Zapata

Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects

Journal Article published May 2018 in Clinical Pharmacology in Drug Development volume 7 issue 4 on pages 435 to 440

Research funded by AbbVie | Genentech

Authors: Tommy T. Cheung, Ahmed Hamed Salem, Rajeev M. Menon, Wijith P. Munasinghe, Orlando F. Bueno, Suresh K. Agarwal

Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis

Journal Article published Mar 2018 in The Journal of Clinical Pharmacology volume 58 issue 3 on pages 386 to 398

Research funded by Genentech

Authors: Xiaohui Wei, Leonid Gibiansky, Yehong Wang, Franklin Fuh, Rich Erickson, Sharon O'Byrne, Meina T. Tang

Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis

Journal Article published Jun 2016 in The Journal of Clinical Pharmacology volume 56 issue 6 on pages 693 to 704

Research funded by Genentech

Authors: Xiaohui Wei, Jane R. Kenny, Leslie Dickmann, Romeo Maciuca, Caroline Looney, Meina T. Tang

Callosal thickness profiles for prognosticating conversion from mild cognitive impairment to Alzheimer’s disease: A classification approach

Journal Article published Dec 2018 in Brain and Behavior volume 8 issue 12

Research funded by AbbVie | Meso Scale Diagnostics | Pfizer | Merck | Roche | Elan | Takeda Pharmaceutical Company | Genentech | National Institutes of Health (U01 AG024904) | U.S. Department of Defense (W81XWH-12-2-0012) | BioClinica | Alzheimer's Drug Discovery Foundation | Fujirebio Europe | Eisai | Northern California Institute for Research and Education | GE Healthcare | Bristol-Myers Squibb | Johnson and Johnson | Pharmaceuticals Bayer | University of Southern California | Novartis | National Institute of Biomedical Imaging and Bioengineering | National Institute on Aging | Health Research | Biogen | Eli Lilly and Company

Authors: Chris Adamson, Richard Beare, Gareth Ball, Mark Walterfang, Marc Seal, the Alzheimer’s Disease Neuroimaging Initiative

A study to investigate the absorption, metabolism, excretion, and bioavailability of oral and intravenous inavolisib in healthy volunteers

Dataset published in http://isrctn.com/

Research funded by Genentech

Authors: Clinical Trials

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach

Journal Article published Nov 2015 in Pharmacoepidemiology and Drug Safety volume 24 issue 11 on pages 1121 to 1132

Research funded by AstraZeneca | Arthritis Research UK (20380) | AbbVie | Amgen | Genentech | Eli Lilly and Company | Novartis | Pfizer | Regeneron Pharmaceuticals | Janssen | Vertex | UCB | CORRONA

Authors: Fredrik Nyberg, Johan Askling, Niklas Berglind, Stefan Franzén, Meilien Ho, Marie Holmqvist, Laura Horne, Kathy Lampl, Kaleb Michaud, Dimitrios A. Pappas, George Reed, Deborah Symmons, Eiichi Tanaka, Trung N. Tran, Suzanne M. M. Verstappen, Eveline Wesby-van Swaay, Hisashi Yamanaka, Jeffrey D. Greenberg